3/A//SEC Filing
Consonance Life Sciences 3/A
Accession 0000899243-21-019978
CIK 0001824893other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 6:19 PM ET
Size
6.0 KB
Accession
0000899243-21-019978
Insider Transaction Report
Form 3/AAmended
Consonance Life Sciences
10% Owner
Holdings
- 2,210,000
Class B Ordinary Shares
Footnotes (4)
- [F1]The shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination.
- [F2]This number includes up to 300,000 shares that are subject to forfeiture in the event the underwriters of the initial public offering of the Issuer's securities do not exercise in full their over-allotment as described in the Issuer's registration statement.
- [F3]These shares are directly held by Consonance Life Sciences, LLC ("Consonance Life Sciences"). This entity is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion with respect to these shares and may be deemed to have shared beneficial ownership of these shares. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
- [F4]This Form 3 amendment is being filed to correct the original Form 3 filed on November 18, 2020. The original Form 3 incorrectly listed the amount of the securities as 2,300,000 Class B Ordinary Shares held by Consonance Life Sciences and incorrectly reported such shares in Table II.
Documents
Issuer
Consonance-HFW Acquisition Corp.
CIK 0001824893
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001824774
Filing Metadata
- Form type
- 3/A
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 6:19 PM ET
- Size
- 6.0 KB